APUS vs HWM · $2.4M cap vs P/E 58, rev $4.86B
Apimeds Pharmaceuticals US, Inc. (APUS) versus Howmet Aerospace Inc (HWM) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Howmet Aerospace Inc (HWM) is a aerospace & defense company listed on US.
APUS does not have a complete income-statement cache yet.
Latest reported HWM revenue for 2026-06-30 was $4.86B. Net income was $1.11B. HWM currently screens at market cap $100.79B and trailing P/E 58.4.
APUS currently screens at market cap $2.4M. HWM currently screens at market cap $100.79B and trailing P/E 58.4.
Not investment advice. Open the APUS and HWM stock pages for the full models.
Not investment advice.